{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T23:45:26Z","timestamp":1769730326735,"version":"3.49.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.clbc.2023.08.005","type":"journal-article","created":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T18:09:48Z","timestamp":1693159788000},"page":"e499-e506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Real-World Evidence on the Use of Endocrine Therapy for Ductal Carcinoma In Situ in Patients Treated With Breast-Conserving Surgery Followed by Postoperative Radiation Therapy: A Brazilian Retrospective Cohort Study"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1960-4715","authenticated-orcid":false,"given":"Cec\u00edlia F\u00e9lix Penido Mendes","family":"de Sousa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan Andresson Lima","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo Viani","family":"Arruda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre Guimaraes","family":"Gouveia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir Abdallah","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo Rocha de Sousa","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Henrique","family":"dos Anjos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Luis Barbosa","family":"Bevilacqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo","family":"Alcantara Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio Ynoe","family":"de Moraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo Nader","family":"Marta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"41","key":"10.1016\/j.clbc.2023.08.005_bib0001","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jncimonographs\/lgq027","article-title":"Epidemiology of ductal carcinoma in situ","volume":"2010","author":"Kerlikowske","year":"2010","journal-title":"J Natl Cancer Inst Monogr"},{"issue":"7","key":"10.1016\/j.clbc.2023.08.005_bib0002","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/jamaoncol.2015.2510","article-title":"Breast cancer mortality after a diagnosis of ductal carcinoma in situ","volume":"1","author":"Narod","year":"2015","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2023.08.005_bib0003","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.breast.2009.04.003","article-title":"Post-operative radiotherapy for ductal carcinoma in situ of the breast: a systematic review of the randomised trials","volume":"18","author":"Goodwin","year":"2009","journal-title":"Breast Edinb Scotl"},{"issue":"32","key":"10.1016\/j.clbc.2023.08.005_bib0004","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.1200\/JCO.21.01083","article-title":"Randomized phase III Trial evaluating radiation following surgical excision for good-risk ductal carcinoma in situ: long-term report from NRG oncology\/RTOG 9804","volume":"39","author":"McCormick","year":"2021","journal-title":"J Clin Oncol"},{"issue":"33","key":"10.1016\/j.clbc.2023.08.005_bib0005","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1200\/JCO.2015.60.8588","article-title":"Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study","volume":"33","author":"Solin","year":"2015","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2023.08.005_bib0006","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1006\/exmp.2001.2366","article-title":"Pathobiologic findings in DCIS of the breast: morphologic features, angiogenesis, HER-2\/neu and hormone receptors","volume":"70","author":"Claus","year":"2001","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.clbc.2023.08.005_bib0007","article-title":"Postoperative tamoxifen for ductal carcinoma in situ","volume":"10","author":"Staley","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.clbc.2023.08.005_bib0008","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/cncr.30425","article-title":"Initiation of and adherence to tamoxifen and aromatase inhibitor therapy among elderly women with ductal carcinoma in situ","volume":"123","author":"Zhao","year":"2017","journal-title":"Cancer"},{"issue":"21","key":"10.1016\/j.clbc.2023.08.005_bib0009","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1200\/JCO.21.00831","article-title":"Cost-effectiveness of adjuvant treatment for ductal carcinoma in situ","volume":"39","author":"Gupta","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2023.08.005_bib0010","unstructured":"UNASUS. Maior sistema p\u00fablico de sa\u00fade do mundo, SUS completa 31 anos. Accessed October 5, 2022. Available at: https:\/\/www.unasus.gov.br\/noticia\/maior-sistema-publico-de-saude-do-mundo-sus-completa-31-anos."},{"key":"10.1016\/j.clbc.2023.08.005_bib0011","unstructured":"FOSP. Funda\u00e7\u00e3o Oncocentro de S\u00e3o Paulo. Accessed January 7, 2023. Available at: https:\/\/fosp.saude.sp.gov.br."},{"key":"10.1016\/j.clbc.2023.08.005_bib0012","unstructured":"IBGE. Estimativas da popula\u00e7\u00e3o residente para os munic\u00edpios e para as unidades da federa\u00e7\u00e3o. Accessed January 7, 2023. Available at: https:\/\/www.ibge.gov.br\/estatisticas\/sociais\/populacao\/9103-estimativas-de-populacao.html?=&t=resultados."},{"issue":"6","key":"10.1016\/j.clbc.2023.08.005_bib0013","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/jnci\/djr027","article-title":"Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS","volume":"103","author":"Wapnir","year":"2011","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.clbc.2023.08.005_bib0014","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1470-2045(10)70266-7","article-title":"Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\/ANZ DCIS trial","volume":"12","author":"Cuzick","year":"2010","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.08.005_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262934","article-title":"Investigating the effectiveness of adjuvant therapy for patients with hormone receptor-positive ductal carcinoma in situ","volume":"17","author":"Tsai","year":"2022","journal-title":"PLOS One"},{"issue":"9","key":"10.1016\/j.clbc.2023.08.005_bib0016","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/annonc\/mdv251","article-title":"Population-based analysis of the impact and generalizability of the NSABP-B24 study on endocrine therapy for patients with ductal carcinoma in situ of the breast","volume":"26","author":"Lo","year":"2015","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2023.08.005_bib0017","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10549-018-4681-6","article-title":"Tamoxifen therapy improves overall survival in luminal A subtype of ductal carcinoma in situ: a study based on nationwide Korean Breast Cancer Registry database","volume":"169","author":"Hwang","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.clbc.2023.08.005_bib0018","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1200\/JCO.2006.10.1022","article-title":"Predictors of tamoxifen discontinuation among older women with estrogen receptor\u2013positive breast cancer","volume":"26","author":"Owusu","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.08.005_bib0019","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1749-6632.2001.tb04012.x","article-title":"Quality of life and tamoxifen in a breast cancer prevention trial","volume":"949","author":"Day","year":"2001","journal-title":"Ann N Y Acad Sci"},{"issue":"8","key":"10.1016\/j.clbc.2023.08.005_bib0020","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1200\/JCO.2015.64.3866","article-title":"Impact of adjuvant endocrine therapy on quality of life and symptoms: observational data over 12 months from the mind-body study","volume":"34","author":"Ganz","year":"2016","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2023.08.005_bib0021","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/GME.0000000000000271","article-title":"Cognitive functioning during long-term tamoxifen treatment in postmenopausal women with breast cancer","volume":"22","author":"Boele","year":"2015","journal-title":"Menopause"},{"issue":"6","key":"10.1016\/j.clbc.2023.08.005_bib0022","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/jamadermatol.2018.0454","article-title":"Endocrine therapy-induced alopecia in patients with breast cancer","volume":"154","author":"Freites-Martinez","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"9793","key":"10.1016\/j.clbc.2023.08.005_bib0023","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(11)60993-8","article-title":"Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials","volume":"378","author":"Davies","year":"2011","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.clbc.2023.08.005_bib0024","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejca.2017.05.002","article-title":"Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: a propensity score-matched cohort study","volume":"82","author":"Hong","year":"2017","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.clbc.2023.08.005_bib0025","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1023\/A:1006250213357","article-title":"Meta-analysis of trials comparing toremifene with tamoxifen and factors predicting outcome of antiestrogen therapy in postmenopausal women with breast cancer","volume":"56","author":"Pyrh\u00f6nen","year":"1999","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"10.1016\/j.clbc.2023.08.005_bib0026","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/cncr.20580","article-title":"The management of ductal carcinoma in situ in North America and Europe. Results of a survey","volume":"101","author":"Ceilley","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.clbc.2023.08.005_bib0027","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.ijrobp.2022.11.010","article-title":"DCIS update: escalation or de-escalation? Boost, fractionation, and omission of radiation","volume":"115","author":"Hepel","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.clbc.2023.08.005_bib0028","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1100","article-title":"Association of radiotherapy with survival in women treated for ductal carcinoma in situ with lumpectomy or mastectomy","volume":"1","author":"Giannakeas","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clbc.2023.08.005_bib0029","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.breast.2022.01.018","article-title":"Moderately hypofractionated post-operative radiation therapy for breast cancer: systematic review and meta-analysis of randomized clinical trials","volume":"62","author":"Marta","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.clbc.2023.08.005_bib0030","article-title":"Moderately hypofractionated radiation therapy for breast cancer: a Brazilian cohort study","volume":"14","author":"de Siqueira","year":"2022","journal-title":"Lancet Reg Health Am"},{"issue":"10237","key":"10.1016\/j.clbc.2023.08.005_bib0031","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Brunt","year":"2020","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.clbc.2023.08.005_bib0032","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S1470-2045(21)00539-8","article-title":"European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer","volume":"23","author":"Meattini","year":"2022","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.clbc.2023.08.005_bib0033","first-page":"1145","article-title":"Accuracy of tumor registry versus pharmacy dispensings for breast cancer adjuvant endocrine therapy","volume":"33","author":"Haas","year":"2022","journal-title":"Cancer Causes Control"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923002124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820923002124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:25:21Z","timestamp":1761513921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820923002124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S1526820923002124"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2023.08.005","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-World Evidence on the Use of Endocrine Therapy for Ductal Carcinoma In Situ in Patients Treated With Breast-Conserving Surgery Followed by Postoperative Radiation Therapy: A Brazilian Retrospective Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2023.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}